Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptide
NOVA2
Reactivity: Human
Host: Synthetic
WB, BP
Catalog No. ABIN980819
Quick Overview for Neuro-Oncological Ventral Antigen 2 (NOVA2) Peptide (ABIN980819)
Target
NOVA2
(Neuro-Oncological Ventral Antigen 2 (NOVA2))
Origin
Human
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-NOVA2 antibody (Catalog #: ARP40399_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
-
Background
-
NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
Alias Symbols: ANOVA, NOVA3
Protein Size: 492 -
Molecular Weight
- 54 kDa
-
Gene ID
- 4858
-
NCBI Accession
- NM_002516, NP_002507
-
UniProt
- Q9UNW9
Target
-
You are here:
